Search Results 1071-1080 of 18361 for Hepatitis C

  1. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

  2. A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension - Mayo Clinic

    ... hepatitis B surface antigen (HBsAg) at the time of Screening. * Established diagnosis of hepatitis C viral infection at the time of screening. * Active and ...

  3. Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients - Mayo Clinic

    There are separate care pathways for patients with a class A and class B CPS and for patients with a class C CPS . In addition, the authors provide an ...

  4. A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

    ... hepatitis B immunization are eligible if other criteria are met (ie, negative tests for : HBsAg, hepatitis B core antibody [HBcAb],and hepatitis C [HCVAb].

  5. News - Ronald C. Petersen, M.D., Ph.D. - Mayo Clinic

    Search. Search for a doctor. Ronald C. Petersen, M.D., Ph.D. Neurologist. Request an Appointment · Overview · News. News.

  6. Selected Publications - Mayo Clinic Research

    Khoury M, Guo Q, Furuta K, Correia C, Meroueh C ... 2024; doi:10.1097/HEP.0000000000000866. McConnell ... 2023; doi:10.1097/HEP.0000000000000207 ...

  7. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    History of liver disease, such as cirrhosis or chronic active hepatitis B and C. Presence of Hepatitis B surface antigen (HbsAg) and/ orPresence of Hepatitis C ...

  8. A Study to Determine the Effectiveness and Safety of Benralizumab for Patients with Severe Nasal Polyposis - Mayo Clinic

    Positive hepatitis B surface antigen, or hepatitis C virus antibody serology ... hepatitis B or C. NOTE: Patients with history of hepatitis B ...

  9. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

    Positive test for Hepatitis B, Hepatitis C, HIV. Current use of immunosuppressant medication or use of such medication within 4 weeks of Screening visit ...

  10. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Active hepatitis B or C with uncontrolled disease;. Note: a detailed assessment of Hepatitis B/C medical history and risk factors must be done at screening ...